Pleiotropic benefit of monomeric and oligomeric flavanols on vascular health - A randomized controlled clinical pilot study

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Weseler, Antje R ^a   Ruijters, Erik J B ^a   Drittij Reijnders, Marie José ^a   Reesink, Koen D ^a   Haenen, Guido R M M ^a   Bast, Aalt ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIN 1; FIBRINOGEN; FLAVANOL DERIVATIVE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LOW DENSITY LIPOPROTEIN; MONOMER; NITRIC OXIDE; OLIGOMER; PLACEBO; PROSTAGLANDIN F2 ALPHA; ANTIOXIDANT; FLAVONOL DERIVATIVE; LIPID;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE; EX VIVO STUDY; GENE EXPRESSION; GRAPE; HUMAN; HUMAN EXPERIMENT; INFLAMMATORY CELL; LEUKOCYTE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MICROVASCULATURE; MORNING DOSAGE; NORMAL HUMAN; OXIDATION REDUCTION STATE; PATIENT COMPLIANCE; PILOT STUDY; PLEIOTROPY; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; BLOOD; BLOOD VESSEL; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; INFLAMMATION; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; VITIS;

ADULT; ANTIOXIDANTS; BLOOD VESSELS; DIETARY SUPPLEMENTS; FIBRINOGEN; FLAVONOLS; HUMANS; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PILOT PROJECTS; PLATELET AGGREGATION; VITIS;

EID: 82955207120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028460     Document Type: Article

References (55)

1. World Health Organization (WHO), Cardiovascular diseases (CVDs), Fact sheet Nr. 317, January 2011. Available: http://www.who.int/mediacentre/factsheets/fs317/en/index.html via the Internet. Accessed 2011 Aug 26.
2. European Heart Network, Cardiovascular disease statistics 2008 Available: http://www.ehnheart.org/cvd-statistics.html via the Internet. Accessed 2011 Aug 26.
3. Mallika V, Goswami B, Rajappa M, (2007) Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 58: 513-522.
4. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM, (2007) Systemic Effects of Smoking. Chest 131: 1557-1566.
5. Pryor WA, Stone K, (1993) Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686: 12-27; discussion 27-18.
6. Powell JT, (1998) Vascular damage from smoking: disease mechanisms at the arterial wall. Vascular Medicine 3: 21-28.
7. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds L-J, (2003) Reactive Oxygen Species Are Involved in Smoking-Induced Dysfunction of Nitric Oxide Biosynthesis and Upregulation of Endothelial Nitric Oxide Synthase: An In Vitro Demonstration in Human Coronary Artery Endothelial Cells. Circulation 107: 2342-2347.
8. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK, (2003) Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States. Ann Intern Med 138: 891-897.
9. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM, (2002) Relation between markers of systemic vascular inflammation and smoking in women. The American Journal of Cardiology 89: 1117-1119.
10. Hughes DA, Haslam PL, Townsend PJ, Turner-Warwick M, (1985) Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol 61: 459-466.
11. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203.
12. Orhan H, Evelo CT, Sahin G, (2005) Erythrocyte antioxidant defense response against cigarette smoking in humans-the glutathione S-transferase vulnerability. J Biochem Mol Toxicol 19: 226-233.
13. Craig WY, Palomaki GE, Haddow JE, (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298: 784-788.
14. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T, (2001) Augmented oxidative stress of platelets in chronic smokers: Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol 38: 1320-1327.
15. Howard G, Wagenknecht L, Burke G, Diez-Roux A, Evans G, et al. (1998) Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in communities (ARIC) study. JAMA 279: 119-124.
16. Leone A, (2003) Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Curr Pharm Des 9: 2417-2423.
17. Fennessy FM, Moneley DS, Wang JH, Kelly CJ, Bouchier-Hayes DJ, (2003) Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers. Circulation 107: 410-415.
18. Heitzer T, Just H, Munzel T, (1996) Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic Smokers. Circulation 94: 6-9.
19. De Lorgeril M, Salen P, Paillard F, Laporte F, Boucher F, et al. (2002) Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res 54: 503-515.
20. Panagiotakos D, Sitara M, Pitsavos C, Stefanadis C, (2007) Estimating the 10-year risk of cardiovascular disease and its economic consequences, by the level of adherence to the Mediterranean diet: the ATTICA study. J Med Food 10: 239-243.
21. Oligomeric proanthocyanidins (OPCs) Monograph (2003). Alternative Medicine Review 8: 442-450.
22. Blade C, Arola L, Salvado MJ, (2010) Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Mol Nutr Food Res 54: 37-59.
23. Chang W-C, Hsu F-L, (1989) Inhibition of platelet aggregation and arachidonate metabolism in platelets by procyanidins. Prostaglandins, Leukotrienes and Essential Fatty Acids 38: 181-188.
24. Sano T, Oda E, Yamashita T, Naemura A, Ijiri Y, et al. (2005) Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Thrombosis Research 115: 115-121.
25. Heaney RP, (2008) Nutrients, endpoints, and the problem of proof. Journal of Nutrition 138: 1591-1595.
26. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, et al. (2005) Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 45: 1987-1993.
27. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265.
28. Giustarini D, Rossi R, Milzani A, Dalle-Donne I, (2008) Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol 440: 361-380.
29. Corraliza IM, Campo ML, Soler G, Modolell M, (1994) Determination of arginase activity in macrophages: a micromethod. Journal of Immunological Methods 174: 231-235.
30. Swennen EL, Bast A, Dagnelie PC, (2005) Immunoregulatory effects of adenosine 5′-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol 35: 852-858.
31. Fischer MA, Gransier TJ, Beckers LM, Bekers O, Bast A, et al. (2005) Determination of the antioxidant capacity in blood. Clin Chem Lab Med 43: 735-740.
32. Julicher RH, Sterrenberg L, Haenen GR, Bast A, Noordhoek J, (1984) Sex differences in the cellular defence system against free radicals from oxygen or drug metabolites in rat. Arch Toxicol 56: 83-86.
33. Griffith OW, (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207-212.
34. Simoons ML, Casparie AF, (1998) Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO. Ned Tijdschr Geneeskd 142: 2096-2101.
35. Fletcher B, Berra K, Ades P, Braun LT, Burke LE, et al. (2005) Managing Abnormal Blood Lipids: A Collaborative Approach. Circulation 112: 3184-3209.
36. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, et al. (2003) Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
37. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, et al. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149-2155.
38. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 97: 1837-1847.
39. Witte DR, van der Graaf Y, Grobbee DE, Bots ML, (2005) Measurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. Atherosclerosis 182: 323-330.
40. van Mierlo LA, Zock PL, van der Knaap HC, Draijer R, (2010) Grape polyphenols do not affect vascular function in healthy men. Journal of Nutrition 140: 1769-1773.
41. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88: 38-50.
42. Ernst E, (2005) The efficacy of herbal medicine-an overview. Fundamental & Clinical Pharmacology 19: 405-409.
43. Gould AL, Davies GM, Alemao E, Yin DD, Cook JR, (2007) Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clinical Therapeutics 29: 778-794.
44. Park YC, Rimbach G, Saliou C, Valacchi G, Packer L, (2000) Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-α secretion, and NF-κB-dependent gene expression in RAW 264.7 macrophages. FEBS Letters 465: 93-97.
45. Petruzzelli S, Puntoni R, Mimotti P, Pulera N, Baliva F, et al. (1997) Plasma 3-nitrotyrosine in cigarette smokers. American Journal of Respiratory and Critical Care Medicine 156: 1902-1907.
46. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, et al. (2003) Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radical Biology and Medicine 35: 1582-1588.
47. Reilly M, Delanty N, Lawson JA, FitzGerald GA, (1996) Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers. Circulation 94: 19-25.
48. Ostertag LM, O'Kennedy N, Kroon PA, Duthie GG, de Roos B, (2010) Impact of dietary polyphenols on human platelet function- a critical review of controlled dietary intervention studies. Mol Nutr Food Res 54: 60-81.
49. Shanmuganayagam D, Beahm MR, Osman HE, Krueger CG, Reed JD, et al. (2002) Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans. Journal of Nutrition 132: 3592-3598.
50. Tarallo P, Henny J, Gueguen R, Siest G, (1992) Reference limits of plasma fibrinogen. Eur J Clin Chem Clin Biochem 30: 745-751.
51. Kakafika AI, Liberopoulos EN, Mikhailidis DP, (2007) Fibrinogen: a predictor of vascular disease. Current Pharmaceutical Design 13: 1647-1659.
52. Schnorr O, Brossette T, Momma TY, Kleinbongard P, Keen CL, et al. (2008) Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476: 211-215.
53. Corder R, Warburton RC, Khan NQ, Brown RE, Wood EG, et al. (2004) The procyanidin-induced pseudo laminar shear stress response: a new concept for the reversal of endothelial dysfunction. Clinical Science (London) 107: 513-517.
54. Moshage H, Kok B, Huizenga JR, Jansen PL, (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry 41: 892-896.
55. van Kreijl CFKA, Busch MCM, Havelaar AH, Kramers PGN, Kromhout D, van Leeuwen FXR, van Leent-Loenen HMJA, Ocke MC, Verkley H, (2004) Ons eten gemeten. Gezonde voeding en veilig voedsel in Nederland. Rijksinstituut voor volksgezondheid en milieu (RIVM). Ministerie voor volksgezondheid, welzijn en sport. RIVM Rapport 270555007.